← Leaderboards
Michio Hirano
Columbia University Health Sciences
$20,704,569
Attributed
$23,826,900
Total exposure
27
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$49,119,814 · 29
By mechanism
U54$30,204,237 · 18
P01$10,518,979 · 3
R01$5,910,265 · 5
T35$1,119,826 · 1
RC1$988,928 · 1
R21$377,579 · 1
Top collaborators
- Salvatore Dimauro19 shared
- John L Thompson12 shared
- Richard Mayeux10 shared
- James Mccallum Noble10 shared
- Jennifer Jaie Manly5 shared
- Russell P. Saneto2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Salvatore Dimauro$5,976,336
- John L Thompson$26,060,206
- Catarina M. Quinzii$4,618,991
- Stephanie Siegmund$187,863
Others in their field
Top investigators on “Mitochondria”
- Bruce M Spiegelman · Dana-Farber Cancer Inst$30,163,696
- Shi Du Yan · Columbia University Health Sciences$29,685,201
- Peipei Ping · University Of California Los Angeles$27,344,561
- Mary McGrae McDermott · Northwestern University$25,752,019
- Vamsi Krishna Mootha · Massachusetts General Hospital$23,004,991
- Kenneth D. Tew · Fox Chase Cancer Center$22,000,362
Research focus
MitochondriaMitochondrial DiseasesBaseResearch PersonnelSiteMitochondrial DnaCollaborationsClinical ResearchProgramsAmericanMutationTissuesSyndromeUnited States National Institutes Of HealthPhenotypeClinical TrialsFundingNatural HistoryGrantDiagnosisPathogenesisMolecularResourcesUniversities
Grant awards (124)
The North American Mitochondrial Disease Consortium (NAMDC)$1,571,080
U54 · FY2023 · NS · contact PI
NAMDC Clinical Registry/Longitudinal Study and Biorepository$425,332
U54 · FY2023 · NS · contact PI
Administrative Core$272,510
U54 · FY2023 · NS · contact PI
Expanded Access Deoxynucleoside Therapy for Thymidine Kinase 2 (TK2) Deficiency$120,721
U54 · FY2023 · NS · contact PI
Pilot$96,761
U54 · FY2023 · NS · contact PI
The North American Mitochondrial Disease Consortium (NAMDC)$1,596,336
U54 · FY2022 · NS · contact PI
NAMDC Clinical Registry/Longitudinal Study and Biorepository$314,782
U54 · FY2022 · NS · contact PI
Administrative Core$197,348
U54 · FY2022 · NS · contact PI
Expanded Access Deoxynucleoside Therapy for Thymidine Kinase 2 (TK2) Deficiency$176,599
U54 · FY2022 · NS · contact PI
The North American Mitochondrial Disease Consortium (NAMDC)$171,622
U54 · FY2022 · NS · contact PI
Pilot$166,794
U54 · FY2022 · NS · contact PI
Brief Research In Aging and Interdisciplinary Neurosciences (BRAIN)$59,612
T35 · FY2022 · AG
The North American Mitochondrial Disease Consortium (NAMDC)$1,621,474
U54 · FY2021 · NS · contact PI
NAMDC Clinical Registry/Longitudinal Study and Biorepository$328,748
U54 · FY2021 · NS · contact PI
Administrative Core$197,348
U54 · FY2021 · NS · contact PI
Expanded Access Deoxynucleoside Therapy for Thymidine Kinase 2 (TK2) Deficiency$179,755
U54 · FY2021 · NS · contact PI
Pilot$166,794
U54 · FY2021 · NS · contact PI
Brief Research In Aging and Interdisciplinary Neurosciences (BRAIN)$133,928
T35 · FY2021 · AG
The North American Mitochondrial Disease Consortium (NAMDC)$1,658,316
U54 · FY2020 · NS · contact PI
NAMDC Clinical Registry/Longitudinal Study and Biorepository$351,140
U54 · FY2020 · NS · contact PI
Administrative Core$197,348
U54 · FY2020 · NS · contact PI
Expanded Access Deoxynucleoside Therapy for Thymidine Kinase 2 (TK2) Deficiency$187,436
U54 · FY2020 · NS · contact PI
Pilot$166,794
U54 · FY2020 · NS · contact PI
Brief Research In Aging and Interdisciplinary Neurosciences (BRAIN)$134,540
T35 · FY2020 · AG
The North American Mitochondrial Disease Consortium (NAMDC)$1,746,884
U54 · FY2019 · NS · contact PI
NAMDC Clinical Registry/Longitudinal Study and Biorepository$363,172
U54 · FY2019 · NS · contact PI
Administrative Core$197,348
U54 · FY2019 · NS · contact PI
Expanded Access Deoxynucleoside Therapy for Thymidine Kinase 2 (TK2) Deficiency$193,747
U54 · FY2019 · NS · contact PI
Therapeutic potential of enhanced mitochondrial biogenesis for paclitaxel-induced peripheral neuropathy$168,779
R21 · FY2019 · CA · contact PI
Pilot$166,794
U54 · FY2019 · NS · contact PI
Brief Research In Aging and Interdisciplinary Neurosciences (BRAIN)$79,535
T35 · FY2019 · AG
MITOCHONDRIAL ENCEPHALOMYOPATHIES: APPROACHES TO TREATMENT$1,546,817
P01 · FY2018 · HD
NAMDC: Overall Research Plan$1,073,130
U54 · FY2018 · NS · contact PI
Project #3 - Pharmacological and gene therapy of TK2 deficiency in mice and human$308,237
P01 · FY2018 · HD · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$280,309
U54 · FY2018 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$248,528
U54 · FY2018 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$244,677
U54 · FY2018 · NS · contact PI
Therapeutic potential of enhanced mitochondrial biogenesis for paclitaxel-induced peripheral neuropathy$208,800
R21 · FY2018 · CA · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$162,718
U54 · FY2018 · NS · contact PI
Brief Research In Aging and Interdisciplinary Neurosciences (BRAIN)$125,021
T35 · FY2018 · AG
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$106,295
U54 · FY2018 · NS · contact PI
Mining the North American Mitochondrial Disease Consortium (NAMDC) Clinical Registry Data to Identify Phenotypes and Outcome Measures for Mitochondrial Diseases$81,000
U54 · FY2018 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$30,603
U54 · FY2018 · NS · contact PI
MITOCHONDRIAL ENCEPHALOMYOPATHIES: APPROACHES TO TREATMENT$1,548,815
P01 · FY2017 · HD
NAMDC: Overall Research Plan$1,088,495
U54 · FY2017 · NS · contact PI
Project #3 - Pharmacological and gene therapy of TK2 deficiency in mice and human$311,499
P01 · FY2017 · HD · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$294,317
U54 · FY2017 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$248,528
U54 · FY2017 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$246,034
U54 · FY2017 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$162,718
U54 · FY2017 · NS · contact PI
The Brief Research in Aging and Interdisciplinary Neurosciences$123,930
T35 · FY2017 · AG
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$106,295
U54 · FY2017 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$30,603
U54 · FY2017 · NS · contact PI
MITOCHONDRIAL ENCEPHALOMYOPATHIES: APPROACHES TO TREATMENT$1,544,137
P01 · FY2016 · HD
NAMDC: Overall Research Plan$1,088,433
U54 · FY2016 · NS · contact PI
Project #3 - Pharmacological and gene therapy of TK2 deficiency in mice and human$311,545
P01 · FY2016 · HD · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$294,317
U54 · FY2016 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$248,528
U54 · FY2016 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$245,972
U54 · FY2016 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$162,718
U54 · FY2016 · NS · contact PI
The Brief Research in Aging and Interdisciplinary Neurosciences$121,824
T35 · FY2016 · AG
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$106,295
U54 · FY2016 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$30,603
U54 · FY2016 · NS · contact PI
MITOCHONDRIAL ENCEPHALOMYOPATHIES: APPROACHES TO TREATMENT$1,537,065
P01 · FY2015 · HD
NAMDC: Overall Research Plan$1,235,912
U54 · FY2015 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$325,006
U54 · FY2015 · NS · contact PI
Project #3 - Pharmacological and gene therapy of TK2 deficiency in mice and human$314,258
P01 · FY2015 · HD · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$248,528
U54 · FY2015 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$247,652
U54 · FY2015 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$162,718
U54 · FY2015 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$145,713
U54 · FY2015 · NS · contact PI
The Brief Research in Aging and Interdisciplinary Neurosciences$119,772
T35 · FY2015 · AG
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$106,295
U54 · FY2015 · NS · contact PI
MITOCHONDRIAL ENCEPHALOMYOPATHIES: APPROACHES TO TREATMENT$1,623,247
P01 · FY2014 · HD
NAMDC: Overall Research Plan$1,250,000
U54 · FY2014 · NS · contact PI
Molecular Pathogenesis and Treatment of MNGIE$382,717
R01 · FY2014 · HD · contact PI
Project #3 - Pharmacological and gene therapy of TK2 deficiency in mice and human$326,845
P01 · FY2014 · HD · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$290,116
U54 · FY2014 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$251,633
U54 · FY2014 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$248,527
U54 · FY2014 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$177,718
U54 · FY2014 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$160,712
U54 · FY2014 · NS · contact PI
Rare Dis Clin Res Consortia (RDCRC) for Rare Dis Clin Res Network (U54)$121,294
U54 · FY2014 · NS · contact PI
The Brief Research in Aging and Interdisciplinary Neurosciences$117,785
T35 · FY2014 · AG
North American Mitochondrial Disease Consortium (NAMDC)$1,085,410
U54 · FY2013 · NS · contact PI
Adminitrative Unit$544,183
U54 · FY2013 · NS · contact PI
Molecular Pathogenesis and Treatment of MNGIE$366,633
R01 · FY2013 · HD · contact PI
AHSCT for MNGIE International Collaborative Trial (AMICT)$182,381
U54 · FY2013 · NS · contact PI
Natural History of MNGIE (NAHIM)$147,112
U54 · FY2013 · NS · contact PI
The Brief Research in Aging and Interdisciplinary Neurosciences$103,879
T35 · FY2013 · AG
North American Mitochondrial Disease Consortium (NAMDC)$1,113,044
U54 · FY2012 · NS · contact PI
Adminitrative Unit$504,657
U54 · FY2012 · NS · contact PI
Molecular Pathogenesis and Treatment of MNGIE$379,077
R01 · FY2012 · HD · contact PI
Molecular Pathogenesis of Coenzyme Q10 Deficiency$285,880
R01 · FY2012 · HD · contact PI
AHSCT for MNGIE International Collaborative Trial (AMICT)$184,727
U54 · FY2012 · NS · contact PI
Natural History of MNGIE (NAHIM)$152,247
U54 · FY2012 · NS · contact PI
Molecular Pathogenesis of Coenzyme Q10 Deficiency$100,000
R01 · FY2012 · HD · contact PI
North American Mitochondrial Disease Consortium (NAMDC)$1,111,697
U54 · FY2011 · NS · contact PI
Adminitrative Unit$450,418
U54 · FY2011 · NS · contact PI
Molecular Pathogenesis and Treatment of MNGIE$400,119
R01 · FY2011 · HD · contact PI
Molecular Pathogenesis of Coenzyme Q10 Deficiency$285,880
R01 · FY2011 · HD · contact PI
AHSCT for MNGIE International Collaborative Trial (AMICT)$190,359
U54 · FY2011 · NS · contact PI
Natural History of MNGIE (NAHIM)$152,079
U54 · FY2011 · NS · contact PI
Molecular Pathogenesis of Coenzyme Q10 Deficiency$100,000
R01 · FY2011 · HD · contact PI
DEVELOPING A NORTH AMERICAN MITOCHONDRIAL DISEASE CONSORTIUM (NAMDC)$492,659
RC1 · FY2010 · NS
Molecular Pathogenesis and Treatment of MNGIE$413,244
R01 · FY2010 · HD · contact PI
Molecular Pathogenesis of Coenzyme Q10 Deficiency$397,238
R01 · FY2010 · HD · contact PI
DEVELOPING A NORTH AMERICAN MITOCHONDRIAL DISEASE CONSORTIUM (NAMDC)$496,269
RC1 · FY2009 · NS
Molecular Pathogenesis of Coenzyme Q10 Deficiency$394,856
R01 · FY2009 · HD · contact PI
Molecular Pathogenesis of Coenzyme Q10 Deficiency$407,518
R01 · FY2008 · HD · contact PI
Molecular Pathogenesis of MNGIE$226,648
P01 · FY2007 · NS · contact PI
Molecular Pathogenesis of MNGIE$236,493
P01 · FY2006 · NS · contact PI
Molecular Pathogenesis of MNGIE$233,958
P01 · FY2005 · NS
Molecular Pathogenesis of MNGIE$227,867
P01 · FY2004 · NS
Pathogenesis of a Novel Limb-Girdle Muscular Dystrophy$388,313
R01 · FY2003 · AR
Molecular Pathogenesis of MNGIE$221,548
P01 · FY2003 · NS
Pathogenesis of a Novel Limb-Girdle Muscular Dystrophy$58,456
R01 · FY2003 · AR
Pathogenesis of a Novel Limb-Girdle Muscular Dystrophy$349,481
R01 · FY2002 · AR
Pathogenesis of a Novel Limb-Girdle Muscular Dystrophy$9,762
R01 · FY2002 · AR
Pathogenesis of a Novel Limb-Girdle Muscular Dystrophy$5,273
R01 · FY2002 · AR
Pathogenesis of a Novel Limb-Girdle Muscular Dystrophy$349,481
R01 · FY2001 · AR
MOLECULAR PATHOGENESIS OF MNGIE SYNDROME$294,561
R01 · FY2001 · HD
MOLECULAR PATHOGENESIS OF MNGIE SYNDROME$286,026
R01 · FY2000 · HD
MITOCHONDRIAL DNA MUTATIONS IN HUMAN CARDIOMYOPATHIES$255,750
R01 · FY2000 · HL